| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $23.29M | - | |
| Other | 138.6K | $7.46M | - | |
| Other | 123.1K | $6.62M | - | |
| CFO | 116.9K | $6.29M | - | |
| Other | 111.5K | $6.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2019 | Aselage Steve80 | Director | Sell | 5,000 | $13.91 | $69,552.50 | -2.0% | |
| Jul 31, 2019 | Rosenberg Noah L. | Chief Medical Officer | Sell | 2,500 | $19.95 | $49,862.50 | -8.1% | |
| May 16, 2019 | McFarlane Neil F. | Chief Operating Officer | Sell | 1,968 | $18.25 | $35,906.16 | -3.5% | |
| May 16, 2019 | Clague Laura64 | Chief Financial Officer | Sell | 2,500 | $18.25 | $45,612.50 | -8.1% | |
| May 15, 2019 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 1,050 | $17.73 | $18,616.50 | -2.6% | |
| May 15, 2019 | Rote William E.58 | Senior Vice President, R&D | Sell | 1,625 | $17.77 | $28,876.26 | -4.2% | |
| May 15, 2019 | Aselage Steve80 | Director | Sell | 3,676 | $17.81 | $65,451.18 | -0.7% | |
| Feb 19, 2019 | Rote William E.58 | Senior Vice President, R&D | Sell | 2,500 | $21.48 | $53,700.00 | -8.0% | |
| Feb 12, 2019 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 1,769 | $21.44 | $37,927.30 | -5.6% | |
| Feb 12, 2019 | Rote William E.58 | Senior Vice President, R&D | Sell | 1,985 | $21.44 | $42,558.34 | -5.7% |